{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T18:00:43Z","timestamp":1773684043038,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.ymgme.2008.07.001","type":"journal-article","created":{"date-parts":[[2008,8,13]],"date-time":"2008-08-13T08:50:35Z","timestamp":1218617435000},"page":"11-16","source":"Crossref","is-referenced-by-count":32,"title":["A 25-year longitudinal analysis of treatment efficacy in inborn errors of metabolism"],"prefix":"10.1016","volume":"95","author":[{"given":"Philippe M.","family":"Campeau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles R.","family":"Scriver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2008.07.001_bib1","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1542\/peds.105.1.e10","article-title":"Incidence of inborn errors of metabolism in British Columbia, 1969\u20131996","volume":"105","author":"Applegarth","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2008.07.001_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1067\/mpd.2002.122394","article-title":"Inborn errors of metabolism in the Italian pediatric population: a national retrospective survey","volume":"140","author":"Dionisi-Vici","year":"2002","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2008.07.001_bib3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/adc.2005.091637","article-title":"The incidence of inherited metabolic disorders in the West Midlands, UK","volume":"91","author":"Sanderson","year":"2006","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2008.07.001_bib4","unstructured":"G. Jimenez-Sanchez, B. Childs, D. Valle, Chapter 4: The effect of mendelian disease on human health, in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds), B. Childs, K.W. Kinzler, B. Vogelstein (Associate Eds.), The Online Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill, New York, NY, 2001\u20132007."},{"key":"10.1016\/j.ymgme.2008.07.001_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajmg.1320210206","article-title":"The effect of Mendelian disease on human health. II: response to treatment","volume":"21","author":"Hayes","year":"1985","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2008.07.001_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ajmg.1320210205","article-title":"The effect of Mendelian disease on human health: a measurement","volume":"21","author":"Costa","year":"1985","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2008.07.001_bib7","first-page":"359","article-title":"Response to treatment in hereditary metabolic disease: 1993 survey and 10-year comparison","volume":"56","author":"Treacy","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2008.07.001_bib8","series-title":"Genetic Medicine: A Logic of Disease","author":"Childs","year":"1999"},{"key":"10.1016\/j.ymgme.2008.07.001_bib9","doi-asserted-by":"crossref","unstructured":"J. Walter, J. Wraith, Treatment Present Status and New Trends, Inborn Metabolic Diseases, 2006, pp. 81\u201397.","DOI":"10.1007\/978-3-540-28785-8_5"},{"key":"10.1016\/j.ymgme.2008.07.001_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajmg.c.30087","article-title":"Disorders of carnitine transport and the carnitine cycle","volume":"142C","author":"Longo","year":"2006","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.ymgme.2008.07.001_bib11","unstructured":"OMIM, Online Mendelian Inheritance in Man (TM), McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD), 2007."},{"key":"10.1016\/j.ymgme.2008.07.001_bib12","unstructured":"C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds), B. Childs, K.W. Kinzler, B. Vogelstein (Associate Eds.), The Online Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill, New York, NY, 2001\u20132007."},{"key":"10.1016\/j.ymgme.2008.07.001_bib13","unstructured":"NIH National Library Medicine. Available from: <http:\/\/www.ClinicalTrials.gov>, 2000\u20132007."},{"key":"10.1016\/j.ymgme.2008.07.001_bib14","unstructured":"Wiley, The Journal of Gene Medicine Clinical Trial. Available from: <http:\/\/www.wiley.co.uk\/genetherapy\/clinical\/>, 2007."},{"key":"10.1016\/j.ymgme.2008.07.001_bib15","unstructured":"WHO, International Clinical Trials Registry Platform. Available from: <www.who.int\/ictrp>, 2007."},{"key":"10.1016\/j.ymgme.2008.07.001_bib16","series-title":"Mendelian Inheritance in Man: Catalogs of Autosomal Dominant, Autosomal Recessive, and X-linked Phenotypes","author":"McKusick","year":"1981"},{"key":"10.1016\/j.ymgme.2008.07.001_bib17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1651-2227.1981.tb06259.x","article-title":"Hyperlysinemia without clinical findings","volume":"70","author":"Ozalp","year":"1981","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.ymgme.2008.07.001_bib18","first-page":"438","article-title":"The prognosis of hyperlysinemia: an interim report","volume":"35","author":"Dancis","year":"1983","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2008.07.001_bib19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/mrdd.20119","article-title":"Changing perspectives on the benefits of newborn screening","volume":"12","author":"Bailey","year":"2006","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2008.07.001_bib20","first-page":"252","article-title":"Newborn screening: toward a uniform screening panel and system","volume":"8","author":"Watson","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2008.07.001_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1034\/j.1399-0004.1998.531530102.x","article-title":"Lumping and splitting: molecular biology in the genetics clinic","volume":"53","author":"Biesecker","year":"1998","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2008.07.001_bib22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1353\/pbm.1969.0039","article-title":"On lumpers and splitters, or the nosology of genetic disease","volume":"12","author":"McKusick","year":"1969","journal-title":"Perspect. Biol. Med."},{"key":"10.1016\/j.ymgme.2008.07.001_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1566524024605815","article-title":"The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies","volume":"2","author":"Moses","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ymgme.2008.07.001_bib24","first-page":"1","article-title":"The natural history of homocystinuria due to cystathionine beta-synthase deficiency","volume":"37","author":"Mudd","year":"1985","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2008.07.001_bib25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ymgme.2005.11.006","article-title":"New frontiers in hereditary metabolic disease: an historical perspective","volume":"87","author":"Cederbaum","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2008.07.001_bib26","unstructured":"D.S. Wishart, Chapter 3.1: metabolism and metabolic disease resources on the Web, in: A.L. Beaudet, W.S. Sly, D. Valle (Eds.), B. Childs, K.W. Kinzler, B. Vogelstein, C.R. Scriver (Associate Eds.), The Online Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill, New York, NY, 2001\u20132008."},{"key":"10.1016\/j.ymgme.2008.07.001_bib27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.510240205","article-title":"Current therapy for Crigler\u2013Najjar syndrome type 1: report of a world registry","volume":"24","author":"van der Veere","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.ymgme.2008.07.001_bib28","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1373\/clinchem.2007.089011","article-title":"Metabolomics identifies perturbations in human disorders of propionate metabolism","volume":"53","author":"Wikoff","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2008.07.001_bib29","doi-asserted-by":"crossref","first-page":"D521","DOI":"10.1093\/nar\/gkl923","article-title":"HMDB: the human metabolome database","volume":"35","author":"Wishart","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymgme.2008.07.001_bib30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nrg1880","article-title":"Inborn errors of metabolism: the flux from Mendelian to complex diseases","volume":"7","author":"Lanpher","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymgme.2008.07.001_bib31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/ng2024","article-title":"Recommendations of the 2006 Human Variome Project meeting","volume":"39","author":"Cotton","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2008.07.001_bib32","doi-asserted-by":"crossref","first-page":"8685","DOI":"10.1073\/pnas.0701361104","article-title":"The human disease network","volume":"104","author":"Goh","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.07.001_bib33","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1097\/01.gim.0000223467.60151.02","article-title":"Main report genetics in medicine newborn screening: toward a uniform screening panel and system","volume":"8","author":"Watson","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2008.07.001_bib34","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s10545-006-0315-y","article-title":"Maple syrup urine disease: favourable effect of early diagnosis by newborn screening on the neonatal course of the disease","volume":"V29","author":"Simon","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2008.07.001_bib35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1651-2227.2004.tb03050.x","article-title":"Inborn errors of metabolism: an update on epidemiology and on neonatal-onset hyperammonemia","volume":"93","author":"Deodato","year":"2004","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2008.07.001_bib36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ymgme.2008.03.005","article-title":"Newborn screening for glutaric aciduria type I in Victoria: treatment and outcome","volume":"94","author":"Boneh","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2008.07.001_bib37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00431-003-1177-z","article-title":"Neonatal screening for citrullinaemia","volume":"162","author":"Sander","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2008.07.001_bib38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ymgme.2007.02.012","article-title":"Prevention of brain disease from severe 5,10-methylenetetrahydrofolate reductase deficiency","volume":"91","author":"Strauss","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2008.07.001_bib39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10545-006-0265-4","article-title":"Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders","volume":"29","author":"Gelb","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2008.07.001_bib40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cca.2005.06.016","article-title":"Quantitative determination of guanidinoacetate and creatine in dried blood spot by flow injection analysis-electrospray tandem mass spectrometry","volume":"364","author":"Carducci","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2008.07.001_bib41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ymgme.2006.05.001","article-title":"Combined liquid chromatography\u2013tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings","volume":"89","author":"Hubbard","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2008.07.001_bib42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ymgme.2006.03.008","article-title":"Retrospective determination of ceruloplasmin in newborn screening blood spots of patients with Wilson disease","volume":"89","author":"Kroll","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2008.07.001_bib43","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1373\/clinchem.2005.063305","article-title":"Use of serum on Guthrie cards in screening for congenital disorders of glycosylation","volume":"52","author":"Carchon","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2008.07.001_bib44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ymgme.2005.09.005","article-title":"Two-tiered universal newborn screening strategy for severe combined immunodeficiency","volume":"86","author":"McGhee","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2008.07.001_bib45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2007.05.012","article-title":"Newborn screening: after the thrill is gone","volume":"92","author":"Vockley","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2008.07.001_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF01800056","article-title":"Newborn urine screening experience with over one million infants in the Quebec Network of Genetic Medicine","volume":"11","author":"Lemieux","year":"1988","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2008.07.001_bib47","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/humu.20526","article-title":"The PAH gene, phenylketonuria, and a paradigm shift","volume":"28","author":"Scriver","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2008.07.001_bib48","first-page":"514","article-title":"Phenylpyruvic oligophrenia deficiency of phenylalanine-oxidizing system","volume":"82","author":"Jervis","year":"1953","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ymgme.2008.07.001_bib49","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0140-6736(53)90473-5","article-title":"Influence of phenylalanine intake on phenylketonuria","volume":"265","author":"Bickel","year":"1953","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2008.07.001_bib50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10545-007-0552-8","article-title":"Phenylketonuria: dietary and therapeutic challenges","volume":"30","author":"Giovannini","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2008.07.001_bib51","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(07)61234-3","article-title":"Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study","volume":"370","author":"Levy","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2008.07.001_bib52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10545-007-0556-4","article-title":"Double blind placebo control trial of large neutral amino acids in treatment of PKU: effect on blood phenylalanine","volume":"30","author":"Matalon","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2008.07.001_bib53","series-title":"PKU and BH4-Advances in Phenylketonuria and Tetrahydrobiopterin","first-page":"350","article-title":"Enzyme therapy for PKU","author":"Sarkissian","year":"2006"},{"key":"10.1016\/j.ymgme.2008.07.001_bib54","doi-asserted-by":"crossref","first-page":"23402","DOI":"10.1074\/jbc.M703367200","article-title":"A novel approach for enzyme replacement therapy: the use of phenylalanine hydroxylase-based fusion proteins for the treatment of phenylketonuria","volume":"282","author":"Eavri","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.07.001_bib55","series-title":"PKU and BH4-Advances in Phenylketonuria and Tetrahydrobiopterin","first-page":"321","article-title":"Gene and cell therapies for phenylketonuria (PKU)","author":"Harding","year":"2006"},{"key":"10.1016\/j.ymgme.2008.07.001_bib56","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/mt.2008.17","article-title":"Correction of murine PKU following AAV-mediated intramuscular expression of a complete phenylalanine hydroxylating system","volume":"16","author":"Ding","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2008.07.001_bib57","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrg1829","article-title":"Genetic medicines: treatment strategies for hereditary disorders","volume":"7","author":"O\u2019Connor","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymgme.2008.07.001_bib58","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrg1828","article-title":"Human monogenic disorders\u2014a source of novel drug targets","volume":"7","author":"Brinkman","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymgme.2008.07.001_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2796.2006.01666.x","article-title":"A journey of hope: lessons learned from studies on rare diseases and orphan drugs","volume":"260","author":"Wastfelt","year":"2006","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ymgme.2008.07.001_bib60","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/GIM.0b013e31802bd96a","article-title":"National collaborative study groups: structure, benefits gained and potential for rare genetic diseases","volume":"8","author":"Moore","year":"2006","journal-title":"Genet. Med."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719208001947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719208001947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T16:58:08Z","timestamp":1588870688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719208001947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":60,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1096719208001947"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2008.07.001","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}